Vertex Pharmaceuticals
VRTX
VRTX
644 hedge funds and large institutions have $35.9B invested in Vertex Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 260 increasing their positions, 205 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $36.1B → $35.9B (-$204M)
9% less call options, than puts
Call options by funds: $206M | Put options by funds: $225M
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
Holders
644
Holding in Top 10
10
Calls
$206M
Puts
$225M
Top Buyers
| 1 | +$275M | |
| 2 | +$219M | |
| 3 | +$102M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$91.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$85.8M |
Top Sellers
| 1 | -$840M | |
| 2 | -$131M | |
| 3 | -$110M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$109M |
| 5 |
Jennison Associates
New York
|
-$71.1M |